Login to Your Account

QuintilesIMS, industry seek unified picture of cancer drugs use

By Michael Fitzhugh
Staff Writer

Wednesday, December 28, 2016

Quintiles IMS Holdings Inc. has formed a new collaborative initiative with four top biopharma companies to ferret out real-world data on the use of cancer treatments across seven top European markets.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription